Concurrent Investment Advisors Boosts Stake in Amgen Amid Q2 Earnings Beat
Concurrent Investment Advisors LLC increased its Amgen Inc. (NASDAQ:AMGN) stake by 19.9% in Q2, according to its latest 13F filing with the SEC.
The firm purchased an additional 8,590 shares during the period, bringing its total holdings to 51,650 shares valued at $18,703,000 as of its most recent filing.
Amgen reported $6.29 earnings per share (EPS) for Q2, surpassing the consensus estimate of $5.62 by $0.67.